SODIUM CHANNELOPATHIES OF SKELETAL MUSCLE AND BRAIN

被引:59
|
作者
Mantegazza, Massimo [1 ,2 ,3 ]
Cestele, Sandrine [1 ,2 ]
Catterall, William A. [4 ]
机构
[1] Univ Cote dAzur, Valbonne, France
[2] CNRS, Inst Pharmacol Mol & Cellulaire, UMR7275, Valbonne, France
[3] INSERM, Valbonne, France
[4] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA
基金
美国国家卫生研究院;
关键词
autism; epilepsy; migraine; periodic paralysis; sodium channels; VOLTAGE-GATED SODIUM; SEVERE MYOCLONIC EPILEPSY; FAMILIAL HEMIPLEGIC MIGRAINE; HYPOKALEMIC PERIODIC PARALYSIS; CHANNEL ALPHA-SUBUNIT; ACTION-POTENTIAL INITIATION; DE-NOVO MUTATIONS; CORTICAL SPREADING DEPRESSION; NEONATAL-INFANTILE SEIZURES; AUTISM SPECTRUM DISORDER;
D O I
10.1152/physrev.00025.2020
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Voltage-gated sodium channels initiate action potentials in nerve, skeletal muscle, and other electrically excitable cells. Mutations in them cause a wide range of diseases. These channelopathy mutations affect every aspect of sodium channel function, including voltage sensing, voltage-dependent activation, ion conductance, fast and slow inactivation, and both biosynthesis and assembly. Mutations that cause different forms of periodic paralysis in skeletal muscle were discovered first and have provided a template for understanding structure, function, and pathophysiology at the molecular level. More recent work has revealed multiple sodium channelopathies in the brain. Here we review the well-characterized genetics and pathophysiology of the periodic paralyses of skeletal muscle and then use this information as a foundation for advancing our understanding of mutations in the structurally homologous alpha-subunits of brain sodium channels that cause epilepsy, migraine, autism, and related comorbidities. We include studies based on molecular and structural biology, cell biology and physiology, pharmacology, and mouse genetics. Our review reveals unexpected connections among these different types of sodium channelopathies.
引用
收藏
页码:1633 / 1689
页数:57
相关论文
共 50 条
  • [1] Skeletal muscle sodium channelopathies
    Nicole, Sophie
    Fontaine, Bertrand
    CURRENT OPINION IN NEUROLOGY, 2015, 28 (05) : 508 - 514
  • [2] Human skeletal muscle sodium channelopathies
    Vicart, S
    Sternberg, D
    Fontaine, B
    Meola, G
    NEUROLOGICAL SCIENCES, 2005, 26 (04) : 194 - 202
  • [3] Human skeletal muscle sodium channelopathies
    S. Vicart
    D. Sternberg
    B. Fontaine
    G. Meola
    Neurological Sciences, 2005, 26 : 194 - 202
  • [4] Pathomechanisms in channelopathies of skeletal muscle and brain
    Cannon, Stephen C.
    ANNUAL REVIEW OF NEUROSCIENCE, 2006, 29 : 387 - 415
  • [5] Mechanistic Diversity for Channelopathies of Brain and Skeletal Muscle
    Cannon, Stephen C.
    BIOPHYSICAL JOURNAL, 2009, 96 (03) : 202A - 202A
  • [6] Phenotypic Variability in Childhood of Skeletal Muscle Sodium Channelopathies
    Yoshinaga, Harumi
    Sakoda, Shunichi
    Shibata, Takashi
    Aldyama, Tomoyuld
    Oka, Makio
    Yuan, Jun-Hui
    Takashima, Hiroshi
    Takahashi, Masanori P.
    Kitamura, Tetsuro
    Murakami, Nagako
    Kobayashi, Katsuhiro
    PEDIATRIC NEUROLOGY, 2015, 52 (05) : 504 - 508
  • [7] Skeletal muscle channelopathies
    Karin Jurkat-Rott
    Holger Lerche
    Frank Lehmann-Horn
    Journal of Neurology, 2002, 249 : 1493 - 1502
  • [8] Skeletal Muscle Channelopathies
    Vivekanandam, Vinojini
    Munot, Pinki
    Hanna, Michael G.
    Matthews, Emma
    NEUROLOGIC CLINICS, 2020, 38 (03) : 481 - 491
  • [9] Skeletal Muscle Channelopathies
    Lauren Phillips
    Jaya R. Trivedi
    Neurotherapeutics, 2018, 15 : 954 - 965
  • [10] Skeletal muscle channelopathies
    Jurkat-Rott, K
    Lerche, H
    Lehmann-Horn, F
    JOURNAL OF NEUROLOGY, 2002, 249 (11) : 1493 - 1502